Jim Cramer labeled Insmed as a very speculative investment on July 15, 2025.
1 report, 1 independent
Updated Jul 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jim Cramer labeled Insmed as a very speculative investment on July 15, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Insmed
company in Bridgewater, United States
Nothing else this week.
-
Jim Cramer
American stockbroker, television personality, author
Related events
- Jim Cramer learned about concentration risk at Goldman Sachs, while SmartAsset promoted related financial advice.
- Jim Cramer commented on GigaCloud's speculative stock status, which is listed on the Nasdaq exchange.
- Jim Cramer addressed concerns regarding the performance of RTX Corporation on October 9, 2026.
- Jim Cramer discussed Fastly's stock performance on August 15, 2025.
- Jim Cramer discussed market progression and defensive stocks on CNBC, referencing comments made by former Goldman Sachs executive Gary Cohn.
Coverage
Newest first; wire copies grouped- Insider MonkeyJim Cramer Calls Insmed “Very Speculative” Insmed Incorporated (NASDAQ:INSM) is one of the stocks on Jim Cramer’s radar. A caller noted that Cramer has not been quick to recommend biotech companies i